PATH has played a major role in discussions around the proposed Kenya Drugs Authority Bill, which had been under development and stakeholder engagement for approximately seven years.

The Kenya Drugs Authority Bill was initiated by the Ministry of Health, with support from parliamentary champions in the National Assembly, and recommendations from partners in the health research and development ecosystem, including PATH.